## Note
nid: 1584309075190
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::MedicalArk, #AK_Step1_v11::#Pixorize::03_Pharm::11_Oncology::Cytarabine, #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::6im, #AK_Step2_v11::!Shelf::IM::no_dupes, #AK_Step2_v11::!Shelf::IM::no_dupes::only_step2, #AK_Step2_v11::#OME_banner, #AK_Step2_v11::#Resources_by_rotation::IM::amboss_medicalark, #AK_Step2_v11::#Subjects::Hematology::03_WBC::03_Lymphoma::Non_Hodgkin_Lymphoma::Primary_CNS_Lymphoma, #AK_Step2_v11::Original_decks::MedicalArk::im::amboss
markdown: false

### Text
<i>Treatment of choice</i> in patients with <b>primary CNS
lymphoma</b> is {{c1::high-dose methotrexate}}

### Extra
PCNSL also responds well to whole-brain radiation
<div>
  In patients with renal insuff‌iciency (glomerular f‌iltration
  rate < 30 mL/min/1.73 m2), alternative chemotherapeutic agents
  such as cytarabine or temozolomide may be used.
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_4.png"></a>
</div>

### Additional Resources


### One by one

